We are live on ! Find out more
MDVL

MedAvail Holdings, Inc. Common Stock

Delisted

MDVL was delisted on the 12th of February, 2024.

6 hedge funds and large institutions have $259K invested in MedAvail Holdings, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

14% less funds holding

Funds holding: 76 (-1)

49% less capital invested

Capital invested by funds: $505K → $259K (-$246K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.65K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$146K
BA
2
Bristlecone Advisors
Washington
$52K
Vanguard Group
3
Vanguard Group
Pennsylvania
$35K +$6.65K +5 +19%
Morgan Stanley
4
Morgan Stanley
New York
$25K -$78.4K -59 -73%
BlackRock
5
BlackRock
New York
$1K
FPF
6
FNY Partners Fund
New York
-$1K -1 Closed
UBS Group
7
UBS Group
Switzerland
-$1K

MDVL Hedge Fund Activity: Q2 2017 in Review

6 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q2 2017, worth a combined $259K — down 49% from $505K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MDVL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $6.65K. The largest seller was Morgan Stanley, cutting an estimated $78.4K.

  • 6 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q2 2017, down from 7 in Q1 2017.
  • Funds reported $259K of MedAvail Holdings, Inc. Common Stock stock for Q2 2017, down 49% quarter-over-quarter.
  • 0 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest MedAvail Holdings, Inc. Common Stock buyer in Q2 2017 was Vanguard Group, an estimated $6.65K added.
  • The largest MedAvail Holdings, Inc. Common Stock seller in Q2 2017 was Morgan Stanley, an estimated $78.4K sold.

Based on aggregated 13F filings for Q2 2017.